HPV Vaccine Hesitancy Survey Among Chinese Adults, 2024

China-based survey of 967 adults in 2024, with a mean age of 33.41 years and 84.4% female participants. The study, authored by Yanqiu Chen, reports an overall HPV vaccine hesitancy rate of 19.86% and analyzes influencing factors using the WHO Vaccine Hesitancy 3Cs model.

Use Cases

• Predicting vaccine hesitancy based on sociodemographic factors and HPV knowledge scores.
• Analyzing the relationship between complacency, confidence, and vaccine hesitancy using the WHO 3Cs model.
• Comparing vaccine hesitancy rates and predictors between male and female populations.
• Developing public health communication strategies based on identified knowledge gaps and attitudinal barriers.

Strengths

• Includes 967 survey responses, providing a substantive sample size.
• Reports specific hesitancy rates: 19.86% overall, 26.5% in men, and 18.6% in women.
• Analyzes data using established scales like the Vaccine Hesitancy Scale and WHO 3Cs model.

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment.
• Data may reflect geographic or demographic bias inherent to the survey methodology.

Provenance

Source

Yanqiu Chen

Collection Method

Cross-sectional survey conducted in China in 2024, using sociodemographic forms, an HPV knowledge questionnaire, the Vaccine Hesitancy Scale, and the WHO Vaccine Hesitancy 3Cs model.

Time Range

2024

Freshness

Last updated 2026-05-25 06:05:54; freshness should be verified.

Geography

China